Mucus

Encyclopedia of Respiratory Medicine, Four-Volume Set

Volumn , Issue , 2006, Pages 62-66

  Rose, M C ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Airway epithelium; Airway mucus; Airway secretions; Asthma; Bronchitis; Cystic fibrosis; Innate defense; Mucin glycoproteins

Indexed keywords

EID: 84866063678     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-12-370879-6/00249-0     Document Type: Chapter

References (18)

1. Adler K.B., Li Y. Airway epithelium and mucus. intracellular signaling pathways for gene expression and secretion. American Journal of Respiratory Cell and Molecular Biology 2001, 25:397-400.
2. Barnes P.J. Current and future therapies for airway mucus hypersecretion. Novartis Foundation Symposium 2002, 248:237-249.
3. Basbaum C., Finkbeiner W. Mucus-producing cells of the airways. Lung Cell Biology 1989, 37-80. Dekker, New York. D. Massaro (Ed.).
4. Basbaum C., Lemjabbar H., Longphre M., et al. Control of mucin transcription by diverse injury-induced signaling pathways. American Journal of Respiratory and Critical Care Medicine 1999, 160:544-548.
5. Boat T.F., Cheng P.W., Iyer R.N., Carlsen D.M., Polony I. Human respiratory tract secretions. mucus glycoproteins of nonpurulent tracheobronchial secretions, and sputum of patients with bronchitis and cystic fibrosis. Archives of Biochemistry and Biophysics 1976, 177:95-104.
6. Boucher R.C. New concepts of the pathogenesis of cystic fibrosis lung disease. European Respiratory Journal 2004, 23:146-158.
7. Casalino-Matsuda S.M., Conner G.E., Salathe M., Forteza R.M. Role of hyaluronan and reactive oxygen species in tissue kallikrein-mediated epidermal growth factor receptor activation in human airways. Journal of Biological Chemistry 2004, 279:21606-21616.
8. Hollingsworth M.A., Swanson B.J. Mucins in cancer. protection and control of the cell surface. Nature Reviews Cancer 2004, 4:45-60.
9. Kirkham S., Sheehan J.K., Knight D., Richardson P.S., Thornton D.J. Heterogeneity of airway mucus. variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochemical Journal 2002, 361:537-546.
10. Knowles M.R., Boucher R.C. Mucus clearance as a primary innate defense mechanism for mammalian airways. Journal of Clinical Investigation 2002, 109:871-877.
11. Rogers D.F. Airway mucus hypersecretion in asthma. an undervalued pathology?. Current Opinion in Pharmacology 2004, 4:241-250.
12. Rose M.C. Characterization of human tracheobronchial mucin glycoproteins. Methods in Enzymology 1989, vol. 179:3-17. Academic Press, New York.
13. Rose M.C., Lynn W.S., Kaufman B. Resolution of the major components of human lung mucosal gel and their capabilities for reaggregation and gel formation. Biochemistry 1979, 18:4030-4037.
14. Rose MC and Voynow JA (2006) Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiological Reviews 86: 245-278.
15. Rubin B.K., Ramirez O., Zayas J.G., Finegan B., King M. Collection and analysis of respiratory mucus from subjects without lung disease. American Review of Respiratory Disease 1990, 141:1040-1043.
16. Salathe M., Forteza R., Conner G.E. Post-secretory fate of host defense components in mucus. Novartis Foundation Symposium 2002, 248:20-26.
17. Thomas P.S., Yates D.H., Barnes P.J. Sputum induction as a method of analyzing pulmonary cells. reproducibility and acceptability. Journal of Asthma 1999, 36:335-341.
18. Vestbo J, Prescott E, Lange P, and The Copenhagen City Heart Study Group (1996) Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. American Journal of Respiratory and Critical Care Medicine 153: 1530-1535.